0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Erectile Dysfunction Drugs Market Research Report 2023
Published Date: January 2023
|
Report Code: QYRE-Auto-7X5184
Home | Market Reports | Health| Reproductive Health
Global Erectile Dysfunction Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Erectile Dysfunction Drugs Market Research Report 2023

Code: QYRE-Auto-7X5184
Report
January 2023
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Erectile Dysfunction Drugs Market Size

The global Erectile Dysfunction Drugs market was valued at US$ 4855 million in 2022 and is anticipated to reach US$ 7335.2 million by 2029, witnessing a CAGR of 6.0% during the forecast period 2023-2029.

Erectile Dysfunction Drugs Market

Erectile Dysfunction Drugs Market

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest Erectile Dysfunction Drugs market with about 39% market share. Europe is follower, accounting for about 30% market share.
The key players are Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO. etc. Top 3 companies occupied about 57% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Drugs.
The Erectile Dysfunction Drugs market size, estimations, and forecasts are provided in terms of sales volume (M Pill) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Erectile Dysfunction Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Erectile Dysfunction Drugs Market Report

Report Metric Details
Report Name Erectile Dysfunction Drugs Market
Accounted market size in 2022 US$ 4855 million
Forecasted market size in 2029 US$ 7335.2 million
CAGR 6.0%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Sildenafil
  • Tadalafil
  • Others
Segment by Application
  • Hospital Pharmacies
  • Private Clinics
  • Retail Pharmacies
  • E-Commerce (B2B)
  • E-Commerce (B2C)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Metuchen Pharma, Seoul Pharma, CSBIO.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Erectile Dysfunction Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.
  • COVID-19 and Russia-Ukraine War Influence Analysis
  • The readers in the section will understand how the Erectile Dysfunction Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
  • Reasons to Buy This Report
  • This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Erectile Dysfunction Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
  • This report will help stakeholders to understand the global industry status and trends of Erectile Dysfunction Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
  • This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
  • This report stays updated with novel technology integration, features, and the latest developments in the market
  • This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Erectile Dysfunction Drugs industry.
  • This report helps stakeholders to gain insights into which regions to target globally
  • This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Erectile Dysfunction Drugs.
  • This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Erectile Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Erectile Dysfunction Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Analysis of sales channel, distributors and customers
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
  • Chapter 11: The main points and conclusions of the report.

FAQ for this report

How fast is Erectile Dysfunction Drugs Market market growing?

Ans: The Erectile Dysfunction Drugs Market market witnessing a CAGR of 6.0% during the forecast period 2023-2029.

What is the Erectile Dysfunction Drugs Market market size in 2029?

Ans: The global Erectile Dysfunction Drugs market was valued at US$ 4855 million in 2022 and is anticipated to reach US$ 7335.2 million by 2029, witnessing a CAGR of 6.0% during the forecast period 2023-2029.

1 Erectile Dysfunction Drugs Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction Drugs
1.2 Erectile Dysfunction Drugs Segment by Type
1.2.1 Global Erectile Dysfunction Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 Erectile Dysfunction Drugs Segment by Application
1.3.1 Global Erectile Dysfunction Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Private Clinics
1.3.4 Retail Pharmacies
1.3.5 E-Commerce (B2B)
1.3.6 E-Commerce (B2C)
1.4 Global Erectile Dysfunction Drugs Market Size Estimates and Forecasts
1.4.1 Global Erectile Dysfunction Drugs Revenue 2018-2029
1.4.2 Global Erectile Dysfunction Drugs Sales 2018-2029
1.4.3 Global Erectile Dysfunction Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Erectile Dysfunction Drugs Market Competition by Manufacturers
2.1 Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Erectile Dysfunction Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Erectile Dysfunction Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Erectile Dysfunction Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Erectile Dysfunction Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erectile Dysfunction Drugs, Product Type & Application
2.7 Erectile Dysfunction Drugs Market Competitive Situation and Trends
2.7.1 Erectile Dysfunction Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Erectile Dysfunction Drugs Players Market Share by Revenue
2.7.3 Global Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Erectile Dysfunction Drugs Retrospective Market Scenario by Region
3.1 Global Erectile Dysfunction Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Erectile Dysfunction Drugs Global Erectile Dysfunction Drugs Sales by Region: 2018-2029
3.2.1 Global Erectile Dysfunction Drugs Sales by Region: 2018-2023
3.2.2 Global Erectile Dysfunction Drugs Sales by Region: 2024-2029
3.3 Global Erectile Dysfunction Drugs Global Erectile Dysfunction Drugs Revenue by Region: 2018-2029
3.3.1 Global Erectile Dysfunction Drugs Revenue by Region: 2018-2023
3.3.2 Global Erectile Dysfunction Drugs Revenue by Region: 2024-2029
3.4 North America Erectile Dysfunction Drugs Market Facts & Figures by Country
3.4.1 North America Erectile Dysfunction Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Erectile Dysfunction Drugs Sales by Country (2018-2029)
3.4.3 North America Erectile Dysfunction Drugs Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Erectile Dysfunction Drugs Market Facts & Figures by Country
3.5.1 Europe Erectile Dysfunction Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Erectile Dysfunction Drugs Sales by Country (2018-2029)
3.5.3 Europe Erectile Dysfunction Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erectile Dysfunction Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Erectile Dysfunction Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Erectile Dysfunction Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Erectile Dysfunction Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Erectile Dysfunction Drugs Market Facts & Figures by Country
3.7.1 Latin America Erectile Dysfunction Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Erectile Dysfunction Drugs Sales by Country (2018-2029)
3.7.3 Latin America Erectile Dysfunction Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erectile Dysfunction Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Erectile Dysfunction Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Erectile Dysfunction Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Erectile Dysfunction Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Erectile Dysfunction Drugs Sales by Type (2018-2029)
4.1.1 Global Erectile Dysfunction Drugs Sales by Type (2018-2023)
4.1.2 Global Erectile Dysfunction Drugs Sales by Type (2024-2029)
4.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Type (2018-2029)
4.2 Global Erectile Dysfunction Drugs Revenue by Type (2018-2029)
4.2.1 Global Erectile Dysfunction Drugs Revenue by Type (2018-2023)
4.2.2 Global Erectile Dysfunction Drugs Revenue by Type (2024-2029)
4.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Erectile Dysfunction Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Erectile Dysfunction Drugs Sales by Application (2018-2029)
5.1.1 Global Erectile Dysfunction Drugs Sales by Application (2018-2023)
5.1.2 Global Erectile Dysfunction Drugs Sales by Application (2024-2029)
5.1.3 Global Erectile Dysfunction Drugs Sales Market Share by Application (2018-2029)
5.2 Global Erectile Dysfunction Drugs Revenue by Application (2018-2029)
5.2.1 Global Erectile Dysfunction Drugs Revenue by Application (2018-2023)
5.2.2 Global Erectile Dysfunction Drugs Revenue by Application (2024-2029)
5.2.3 Global Erectile Dysfunction Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Erectile Dysfunction Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Eli Lilly Erectile Dysfunction Drugs Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Erectile Dysfunction Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bayer Erectile Dysfunction Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Corporation Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BaiYunShan General Factory Erectile Dysfunction Drugs Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Corporation Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 S.K. Chemicals Erectile Dysfunction Drugs Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Corporation Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teva Pharma Erectile Dysfunction Drugs Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.6.1 Dong-A ST Corporation Information
6.6.2 Dong-A ST Description and Business Overview
6.6.3 Dong-A ST Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dong-A ST Erectile Dysfunction Drugs Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Metuchen Pharma
6.8.1 Metuchen Pharma Corporation Information
6.8.2 Metuchen Pharma Description and Business Overview
6.8.3 Metuchen Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Metuchen Pharma Erectile Dysfunction Drugs Product Portfolio
6.8.5 Metuchen Pharma Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Corporation Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Seoul Pharma Erectile Dysfunction Drugs Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 CSBIO.
6.10.1 CSBIO. Corporation Information
6.10.2 CSBIO. Description and Business Overview
6.10.3 CSBIO. Erectile Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 CSBIO. Erectile Dysfunction Drugs Product Portfolio
6.10.5 CSBIO. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erectile Dysfunction Drugs Industry Chain Analysis
7.2 Erectile Dysfunction Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erectile Dysfunction Drugs Production Mode & Process
7.4 Erectile Dysfunction Drugs Sales and Marketing
7.4.1 Erectile Dysfunction Drugs Sales Channels
7.4.2 Erectile Dysfunction Drugs Distributors
7.5 Erectile Dysfunction Drugs Customers
8 Erectile Dysfunction Drugs Market Dynamics
8.1 Erectile Dysfunction Drugs Industry Trends
8.2 Erectile Dysfunction Drugs Market Drivers
8.3 Erectile Dysfunction Drugs Market Challenges
8.4 Erectile Dysfunction Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Erectile Dysfunction Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
    Table 2. Global Erectile Dysfunction Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
    Table 3. Global Erectile Dysfunction Drugs Market Competitive Situation by Manufacturers in 2022
    Table 4. Global Erectile Dysfunction Drugs Sales (M Pill) of Key Manufacturers (2018-2023)
    Table 5. Global Erectile Dysfunction Drugs Sales Market Share by Manufacturers (2018-2023)
    Table 6. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
    Table 7. Global Erectile Dysfunction Drugs Revenue Share by Manufacturers (2018-2023)
    Table 8. Global Market Erectile Dysfunction Drugs Average Price (USD/Pill) of Key Manufacturers (2018-2023)
    Table 9. Global Key Players of Erectile Dysfunction Drugs, Industry Ranking, 2021 VS 2022 VS 2023
    Table 10. Global Key Manufacturers of Erectile Dysfunction Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Erectile Dysfunction Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Erectile Dysfunction Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Erectile Dysfunction Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Drugs as of 2022)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Erectile Dysfunction Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 17. Global Erectile Dysfunction Drugs Sales by Region (2018-2023) & (M Pill)
    Table 18. Global Erectile Dysfunction Drugs Sales Market Share by Region (2018-2023)
    Table 19. Global Erectile Dysfunction Drugs Sales by Region (2024-2029) & (M Pill)
    Table 20. Global Erectile Dysfunction Drugs Sales Market Share by Region (2024-2029)
    Table 21. Global Erectile Dysfunction Drugs Revenue by Region (2018-2023) & (US$ Million)
    Table 22. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2018-2023)
    Table 23. Global Erectile Dysfunction Drugs Revenue by Region (2024-2029) & (US$ Million)
    Table 24. Global Erectile Dysfunction Drugs Revenue Market Share by Region (2024-2029)
    Table 25. North America Erectile Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 26. North America Erectile Dysfunction Drugs Sales by Country (2018-2023) & (M Pill)
    Table 27. North America Erectile Dysfunction Drugs Sales by Country (2024-2029) & (M Pill)
    Table 28. North America Erectile Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 29. North America Erectile Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 30. Europe Erectile Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 31. Europe Erectile Dysfunction Drugs Sales by Country (2018-2023) & (M Pill)
    Table 32. Europe Erectile Dysfunction Drugs Sales by Country (2024-2029) & (M Pill)
    Table 33. Europe Erectile Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 34. Europe Erectile Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 35. Asia Pacific Erectile Dysfunction Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
    Table 36. Asia Pacific Erectile Dysfunction Drugs Sales by Region (2018-2023) & (M Pill)
    Table 37. Asia Pacific Erectile Dysfunction Drugs Sales by Region (2024-2029) & (M Pill)
    Table 38. Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2018-2023) & (US$ Million)
    Table 39. Asia Pacific Erectile Dysfunction Drugs Revenue by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Erectile Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 41. Latin America Erectile Dysfunction Drugs Sales by Country (2018-2023) & (M Pill)
    Table 42. Latin America Erectile Dysfunction Drugs Sales by Country (2024-2029) & (M Pill)
    Table 43. Latin America Erectile Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 44. Latin America Erectile Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 45. Middle East & Africa Erectile Dysfunction Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
    Table 46. Middle East & Africa Erectile Dysfunction Drugs Sales by Country (2018-2023) & (M Pill)
    Table 47. Middle East & Africa Erectile Dysfunction Drugs Sales by Country (2024-2029) & (M Pill)
    Table 48. Middle East & Africa Erectile Dysfunction Drugs Revenue by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Erectile Dysfunction Drugs Revenue by Country (2024-2029) & (US$ Million)
    Table 50. Global Erectile Dysfunction Drugs Sales (M Pill) by Type (2018-2023)
    Table 51. Global Erectile Dysfunction Drugs Sales (M Pill) by Type (2024-2029)
    Table 52. Global Erectile Dysfunction Drugs Sales Market Share by Type (2018-2023)
    Table 53. Global Erectile Dysfunction Drugs Sales Market Share by Type (2024-2029)
    Table 54. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Type (2018-2023)
    Table 55. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Type (2024-2029)
    Table 56. Global Erectile Dysfunction Drugs Revenue Market Share by Type (2018-2023)
    Table 57. Global Erectile Dysfunction Drugs Revenue Market Share by Type (2024-2029)
    Table 58. Global Erectile Dysfunction Drugs Price (USD/Pill) by Type (2018-2023)
    Table 59. Global Erectile Dysfunction Drugs Price (USD/Pill) by Type (2024-2029)
    Table 60. Global Erectile Dysfunction Drugs Sales (M Pill) by Application (2018-2023)
    Table 61. Global Erectile Dysfunction Drugs Sales (M Pill) by Application (2024-2029)
    Table 62. Global Erectile Dysfunction Drugs Sales Market Share by Application (2018-2023)
    Table 63. Global Erectile Dysfunction Drugs Sales Market Share by Application (2024-2029)
    Table 64. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Application (2018-2023)
    Table 65. Global Erectile Dysfunction Drugs Revenue (US$ Million) by Application (2024-2029)
    Table 66. Global Erectile Dysfunction Drugs Revenue Market Share by Application (2018-2023)
    Table 67. Global Erectile Dysfunction Drugs Revenue Market Share by Application (2024-2029)
    Table 68. Global Erectile Dysfunction Drugs Price (USD/Pill) by Application (2018-2023)
    Table 69. Global Erectile Dysfunction Drugs Price (USD/Pill) by Application (2024-2029)
    Table 70. Eli Lilly Corporation Information
    Table 71. Eli Lilly Description and Business Overview
    Table 72. Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
    Table 73. Eli Lilly Erectile Dysfunction Drugs Product
    Table 74. Eli Lilly Recent Developments/Updates
    Table 75. Pfizer Corporation Information
    Table 76. Pfizer Description and Business Overview
    Table 77. Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
    Table 78. Pfizer Erectile Dysfunction Drugs Product
    Table 79. Pfizer Recent Developments/Updates
    Table 80. Bayer Corporation Information
    Table 81. Bayer Description and Business Overview
    Table 82. Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
    Table 83. Bayer Erectile Dysfunction Drugs Product
    Table 84. Bayer Recent Developments/Updates
    Table 85. BaiYunShan General Factory Corporation Information
    Table 86. BaiYunShan General Factory Description and Business Overview
    Table 87. BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
    Table 88. BaiYunShan General Factory Erectile Dysfunction Drugs Product
    Table 89. BaiYunShan General Factory Recent Developments/Updates
    Table 90. S.K. Chemicals Corporation Information
    Table 91. S.K. Chemicals Description and Business Overview
    Table 92. S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
    Table 93. S.K. Chemicals Erectile Dysfunction Drugs Product
    Table 94. S.K. Chemicals Recent Developments/Updates
    Table 95. Teva Pharma Corporation Information
    Table 96. Teva Pharma Description and Business Overview
    Table 97. Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
    Table 98. Teva Pharma Erectile Dysfunction Drugs Product
    Table 99. Teva Pharma Recent Developments/Updates
    Table 100. Dong-A ST Corporation Information
    Table 101. Dong-A ST Description and Business Overview
    Table 102. Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
    Table 103. Dong-A ST Erectile Dysfunction Drugs Product
    Table 104. Dong-A ST Recent Developments/Updates
    Table 105. Metuchen Pharma Corporation Information
    Table 106. Metuchen Pharma Description and Business Overview
    Table 107. Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
    Table 108. Metuchen Pharma Erectile Dysfunction Drugs Product
    Table 109. Metuchen Pharma Recent Developments/Updates
    Table 110. Seoul Pharma Corporation Information
    Table 111. Seoul Pharma Description and Business Overview
    Table 112. Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
    Table 113. Seoul Pharma Erectile Dysfunction Drugs Product
    Table 114. Seoul Pharma Recent Developments/Updates
    Table 115. CSBIO. Corporation Information
    Table 116. CSBIO. Description and Business Overview
    Table 117. CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (US$ Million), Price (USD/Pill) and Gross Margin (2018-2023)
    Table 118. CSBIO. Erectile Dysfunction Drugs Product
    Table 119. CSBIO. Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Erectile Dysfunction Drugs Distributors List
    Table 123. Erectile Dysfunction Drugs Customers List
    Table 124. Erectile Dysfunction Drugs Market Trends
    Table 125. Erectile Dysfunction Drugs Market Drivers
    Table 126. Erectile Dysfunction Drugs Market Challenges
    Table 127. Erectile Dysfunction Drugs Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Erectile Dysfunction Drugs
    Figure 2. Global Erectile Dysfunction Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
    Figure 3. Global Erectile Dysfunction Drugs Market Share by Type in 2022 & 2029
    Figure 4. Sildenafil Product Picture
    Figure 5. Tadalafil Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Erectile Dysfunction Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
    Figure 8. Global Erectile Dysfunction Drugs Market Share by Application in 2022 & 2029
    Figure 9. Hospital Pharmacies
    Figure 10. Private Clinics
    Figure 11. Retail Pharmacies
    Figure 12. E-Commerce (B2B)
    Figure 13. E-Commerce (B2C)
    Figure 14. Global Erectile Dysfunction Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Erectile Dysfunction Drugs Market Size (2018-2029) & (US$ Million)
    Figure 16. Global Erectile Dysfunction Drugs Sales (2018-2029) & (M Pill)
    Figure 17. Global Erectile Dysfunction Drugs Average Price (USD/Pill) & (2018-2029)
    Figure 18. Erectile Dysfunction Drugs Report Years Considered
    Figure 19. Erectile Dysfunction Drugs Sales Share by Manufacturers in 2022
    Figure 20. Global Erectile Dysfunction Drugs Revenue Share by Manufacturers in 2022
    Figure 21. The Global 5 and 10 Largest Erectile Dysfunction Drugs Players: Market Share by Revenue in 2022
    Figure 22. Erectile Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 23. Global Erectile Dysfunction Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Figure 24. North America Erectile Dysfunction Drugs Sales Market Share by Country (2018-2029)
    Figure 25. North America Erectile Dysfunction Drugs Revenue Market Share by Country (2018-2029)
    Figure 26. U.S. Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 27. Canada Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 28. Europe Erectile Dysfunction Drugs Sales Market Share by Country (2018-2029)
    Figure 29. Europe Erectile Dysfunction Drugs Revenue Market Share by Country (2018-2029)
    Figure 30. Germany Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 31. France Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 32. U.K. Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Italy Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Russia Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 35. Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Region (2018-2029)
    Figure 36. Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Region (2018-2029)
    Figure 37. China Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 38. Japan Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 39. South Korea Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 40. India Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 41. Australia Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 42. China Taiwan Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 43. Indonesia Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 44. Thailand Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 45. Malaysia Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 46. Latin America Erectile Dysfunction Drugs Sales Market Share by Country (2018-2029)
    Figure 47. Latin America Erectile Dysfunction Drugs Revenue Market Share by Country (2018-2029)
    Figure 48. Mexico Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Argentina Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Middle East & Africa Erectile Dysfunction Drugs Sales Market Share by Country (2018-2029)
    Figure 52. Middle East & Africa Erectile Dysfunction Drugs Revenue Market Share by Country (2018-2029)
    Figure 53. Turkey Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 55. UAE Erectile Dysfunction Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
    Figure 56. Global Sales Market Share of Erectile Dysfunction Drugs by Type (2018-2029)
    Figure 57. Global Revenue Market Share of Erectile Dysfunction Drugs by Type (2018-2029)
    Figure 58. Global Erectile Dysfunction Drugs Price (USD/Pill) by Type (2018-2029)
    Figure 59. Global Sales Market Share of Erectile Dysfunction Drugs by Application (2018-2029)
    Figure 60. Global Revenue Market Share of Erectile Dysfunction Drugs by Application (2018-2029)
    Figure 61. Global Erectile Dysfunction Drugs Price (USD/Pill) by Application (2018-2029)
    Figure 62. Erectile Dysfunction Drugs Value Chain
    Figure 63. Erectile Dysfunction Drugs Production Process
    Figure 64. Channels of Distribution (Direct Vs Distribution)
    Figure 65. Distributors Profiles
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS